Evidence map›Paper›PMID 31685965›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).

M Varma, J R Srigley, F Brimo, E Compérat, B Delahunt, M Koch, A Lopez-Beltran, V Reuter, H Samaratunga, J H Shanks and 4 more

Abstract readDatasetMulticenter Study
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. 2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. T1 bladder carcinoma with variant histology: pathological features and clinical significance.Virchows Archiv : an international journal of pathology · 2022
    Article
  8. Review
  9. Article
  10. Frontiers in oncology · 2021
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M VarmaDepartment of Cellular Pathology, University Hospital of Wales, Cardiff, UK. wptmv@cf.ac.uk.ORCID http://orcid.org/0000-0003-1385-2045
J R SrigleyDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
F BrimoDepartment of Pathology, McGill University Health Center, Montréal, QC, Canada.
E CompératDepartment of Pathology, Hopital Tenon, HUEP, Sorbonne University, Paris, France.
B DelahuntDepartment of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
M KochDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
A Lopez-BeltranDepartment of Pathology, Champalimaud Clinical Center, Lisbon, Portugal.
V ReuterDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
H SamaratungaAquesta Specialized Uropathology, Brisbane, QLD, Australia.
J H ShanksDepartment of Histopathology, The Christie NHS Foundation Trust, Manchester, UK.
T TsuzukiDepartment of Pathology, Aichi Medical University, Aichi, Japan.ORCID http://orcid.org/0000-0002-4855-4366
T van der KwastLaboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada.
F WebsterInternational Collaboration on Cancer Reporting, Sydney, NSW, Australia.
D GrignonDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, IUH Pathology Laboratory, Indianapolis, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The International Collaboration on Cancer Reporting (ICCR) is an alliance of major pathology organisations in Australasia, Canada, Europe, United Kingdom, and United States of America that develops internationally standardised, evidence-based datasets for the pathology reporting of cancer specimens. This dataset was developed by a multidisciplinary panel of international experts based on previously published ICCR guidelines for the production of cancer datasets. It is composed of Required (core) and Recommended (noncore) elements identified on the basis of literature review and expert consensus. The document also includes an explanatory commentary explaining the rationale behind the categorization of individual data items and provides guidance on how these should be collected and reported. The dataset includes nine required and six recommended elements for the reporting of cancers of the urinary tract in biopsy and transurethral resection (TUR) specimens. The required elements include specimen site, operative procedure, histological tumor type, subtype/variant of urothelial carcinoma, tumor grade, extent of invasion, status of muscularis propria, noninvasive carcinoma, and lymphovascular invasion (LVI). The recommended elements include clinical information, block identification key, extent of T1 disease, associated epithelial lesions, coexistent pathology, and ancillary studies. The dataset provides a structured template for globally harmonized collection of pathology data required for management of patients diagnosed with cancer of the urinary tract in biopsy and TUR specimens. It is expected that this will facilitate international collaboration, reduce duplication of effort in updating current national/institutional datasets, and be particularly useful for countries that have not developed their own datasets.

Indexed as

BiopsyCarcinomaConsensusData AccuracyHumansNeoplasm InvasivenessNeoplasm StagingPathologyPredictive Value of TestsUrologic Neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.